EP3897646
MACITENTAN TIL NOTKUNAR VIÐ MEÐFERÐ GEGN LUNGNASLAGÆÐAHÁÞRÝSTINGI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.12.2019EP published:
22.5.2024EP application number:
19832954.2
EP translation filed:
24.6.2024Grant published:
15.8.2024EPO information:
European Patent Register
Max expiry date:
19.12.2039Expiry date:
19.12.2026Next due date:
31.12.2026
Title in English:
MACITENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSIONLanguage of the patent:
English
Timeline
Today
20.12.2019EP application
22.5.2024EP Publication
24.6.2024Translation submitted
15.8.2024Registration published
19.12.2026Expires
Owner
Name:
Actelion Pharmaceuticals LtdAddress:
Gewerbestrasse 16, 4123 Allschwil, CH
Inventor
Name:
CSONKA, DénesAddress:
4123 Allschwil, CH
Name:
FARES, WassimAddress:
Raritan NJ 08869, US
Name:
HOOGKAMER, HansAddress:
4123 Allschwil, CH
Name:
TORFS, KoenAddress:
2340 Beerse, BE
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
PCT/EP2018/086724Date:
21.12.2018Country:
WO
Number:
PCT/EP2019/051830Date:
25.1.2019Country:
WO
Number:
PCT/EP2019/060151Date:
18.4.2019Country:
WO
Number:
PCT/EP2019/066494Date:
21.6.2019Country:
WO
Number:
PCT/EP2019/067186Date:
27.6.2019Country:
WO
Classification
Categories:
A61K 31/506, A61P 9/12, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.11.2024
Expires: 19.12.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.12.2025
Expires: 19.12.2026
Payer: Árnason Faktor ehf.